Chimerix Inc (CMRX) Drops Ebola Vaccine Testing In Liberia

February 2, 2015 11:26 AM

10 0

Chimerix announced it has ended testing of its experimental antiviral in Ebola patients in Liberia, as the number of Ebola cases have reduced significantly

Chimerix Inc (NASDAQ:CMRX) announced late Friday that it has ended testing of its experimental antiviral vaccine in Ebola patients in Liberia, citing a decline in the number of new Ebola cases in recent weeks as the reason for the decision.

Read more

To category page

Loading...